Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40(5):602–8.

Article  CAS  PubMed  Google Scholar 

Ahmad S, Sayeed S, Bano N, Sheikh K, Raza K. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against cervical cancer. J Biomol Struct Dyn. 2023;41(19):9770–86.

Article  CAS  PubMed  Google Scholar 

Cohen PA, et al. Cervical cancer. Lancet. 2019;393(10167):169–82.

Article  PubMed  Google Scholar 

Šarenac T, Mikov M. Cervical cancer, different treatments and importance of bile acids as therapeutic agents in this disease. Front Pharmacol. 2019;10:484.

Article  PubMed  PubMed Central  Google Scholar 

Vizcaino AP, et al. International trends in incidence of cervical cancer: II squamous-cell carcinoma. Int J Cancer. 2000;86(3):429–35.

Article  CAS  PubMed  Google Scholar 

Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J. 2003;9(5):348–59.

Article  PubMed  Google Scholar 

Singh D, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health. 2023;11(2):e197–206.

Article  CAS  PubMed  Google Scholar 

Arbyn M, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–203.

Article  PubMed  Google Scholar 

Giesecke A, Stewart M. Novel binding of the mitotic regulator TPX2 (target protein for Xenopus kinesin-like protein 2) to importin-α. J Biol Chem. 2010;285(23):17628–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu L, Jiang Y, Zhao R. Advances in ablative treatment for human papillomavirus related cervical pre-cancer lesions. Gynecol Obstetrics Clin Med. 2023. https://doi.org/10.1016/j.gocm.2023.11.002.

Article  Google Scholar 

WHO. Strategic framework for the comprehensive prevention and control of cervical cancer in the Western Pacific Region 2023–2030. Geneva: WHO; 2023.

Google Scholar 

Allanson ER, Schmeler KM. Preventing cervical cancer globally: are we making progress? Cancer Prev Res. 2021;14(12):1055–60.

Article  Google Scholar 

Chen C-C, et al. Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells. Cancer Cell Int. 2015;15:1–9.

Article  Google Scholar 

Almasoudi HH, et al. Structure-based in silico approaches reveal IRESSA as a multitargeted breast cancer regulatory, signalling, and receptor protein inhibitor. Pharmaceuticals. 2024;17(2):208.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Almasoudi HH, et al. Molecular screening reveals Variolin B as a multitargeted inhibitor of lung cancer: a molecular docking-based fingerprinting and molecular dynamics simulation study. J Biomol Struct Dyn. 2024;42(1):11–21.

Article  CAS  PubMed  Google Scholar 

Ahmad S, et al. Deep learning in computer-aided drug design: a case study. In: Deep learning applications in translational bioinformatics. NY: Academic Press; 2024. p. 191–210.

Chapter  Google Scholar 

Ahmad S, et al. Reporting multitargeted potency of Tiaprofenic acid against lung cancer: molecular fingerprinting, MD simulation, and MTT-based cell viability assay studies. Int J Biol Macromol. 2024;276:133872.

Article  CAS  PubMed  Google Scholar 

Ahmad S, et al. Multitargeted molecular dynamic understanding of butoxypheser against SARS-CoV-2: an in silico study. Nat Prod Commun. 2022;17(7):1934578X221115499.

CAS  Google Scholar 

Ahmad S, et al. Therapeutic protein-based vaccines. In: Protein-based therapeutics. Singapore: Springer; 2023. p. 355–84.

Chapter  Google Scholar 

Alsalmi O, et al. Variolin B from sea sponge against lung cancer: a multitargeted molecular docking with fingerprinting and molecular dynamics simulation study. J Biomol Struct Dyn. 2024;42(7):3507–19.

Article  CAS  PubMed  Google Scholar 

Binshaya AS, et al. Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer. Med Oncol. 2024;41(5):101.

Article  CAS  PubMed  Google Scholar 

Ahmad S, et al. Natural product-based drug designing for treatment of human parasitic diseases. In: Natural product based drug discovery against human parasites: opportunities and challenges. Cham: Springer; 2023. p. 37–59.

Chapter  Google Scholar 

Ahmad S, et al. Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: An in-silico study. J Biomol Struct Dyn. 2023;41(9):4013–23.

Article  CAS  PubMed  Google Scholar 

Ahmad S, Raza K. Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study. Mol Div. 2024;28(3):1189–202.

Article  CAS  Google Scholar 

Petri ET, et al. The crystal structure of human cyclin B. Cell Cycle. 2007;6(11):1342–9.

Article  CAS  PubMed  Google Scholar 

D’Arcy S, et al. Defining the molecular basis of BubR1 kinetochore interactions and APC/C-CDC20 inhibition. J Biol Chem. 2010;285(19):14764–76.

Article  PubMed  PubMed Central  Google Scholar 

Makyio H, et al. Structural basis for Arf6–MKLP1 complex formation on the Flemming body responsible for cytokinesis. EMBO J. 2012;31(11):2590–603.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Almasoudi HH, et al. Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study. Med Oncol. 2023;40(8):218.

Article  CAS  PubMed  Google Scholar 

Ahmad S, Raza K. An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives. J Drug Target. 2024;32(6):635–46.

Article  CAS  PubMed  Google Scholar 

Ahmad S, et al. Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis. Int J Biol Macromol. 2024. https://doi.org/10.1016/j.ijbiomac.2024.132332.

Article  PubMed  Google Scholar 

Ahmad S, et al. Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and in-vitro study. J Biomol Struct Dyn. 2024;42(5):2494–511.

Article  CAS  PubMed  Google Scholar 

Sahu A, et al. In-silico and in-vitro study reveals Ziprasidone as a potential aromatase inhibitor against breast carcinoma. Sci Rep. 2023;13(1):16545.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shah AA, et al. Structure-based virtual screening, molecular docking, molecular dynamics simulation, and metabolic reactivity studies of quinazoline derivatives for their anti-EGFR activity against tumor angiogenesis. Curr Med Chem. 2024;31(5):595–619.

Article  CAS  PubMed  Google Scholar 

Shelley JC, et al. Epik: a software program for pK a prediction and protonation state generation for drug-like molecules. J Comput Aided Mol Des. 2007;21:681–91.

Article  CAS  PubMed